Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels

Gen Hosp Psychiatry. 2003 Nov-Dec;25(6):495-6. doi: 10.1016/s0163-8343(03)00093-8.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / adverse effects*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / psychology
  • Bupropion / administration & dosage
  • Bupropion / adverse effects*
  • Crohn Disease / immunology
  • Crohn Disease / psychology
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / immunology
  • Depressive Disorder / psychology
  • Humans
  • Inflammation / chemically induced*
  • Inflammation / immunology
  • Inflammation / prevention & control*
  • Mianserin / adverse effects*
  • Mianserin / analogs & derivatives*
  • Mirtazapine
  • Neoplasms / immunology
  • Neoplasms / psychology
  • Risk Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antidepressive Agents
  • Tumor Necrosis Factor-alpha
  • Bupropion
  • Mianserin
  • Mirtazapine